Quality, opportunity, and treatment of data of tuberculosis and human immunodeficiency virus co-infection

被引:0
作者
Soares, Karllian Kerlen Simonelli [1 ,4 ]
Hisatugu, Wilian Hiroshi [1 ]
de Souza, Fernanda Mattos [2 ]
Costa, Ana Paula Rodrigues [1 ,3 ]
Andrade, Romildo Luiz Monteiro [1 ,3 ]
Maciel, Ethel Leonor Noia [1 ]
do Prado, Nascimento [1 ]
机构
[1] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil
[2] Univ Estado Rio de Janeiro UERJ, Rio De Janeiro, Brazil
[3] Secretaria Estado Saude Espirito Santo, Vitoria, ES, Brazil
[4] 1468 Ave Marechal Campos,Maruipe, Vitoria, ES, Brazil
来源
REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO | 2023年 / 13卷 / 02期
关键词
Epidemiology; Tuberculosis; HIV; Health Information Systems; Co-infection; SYSTEM; CHINA;
D O I
10.17058/reci.v13i2.18102
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: The identification, evaluation, and use of methodological resources for data quality analysis is important to support planning actions of public policies for the control of tuberculosis (TB) and the co-infection TB and human immunodeficiency virus (HIV). The objective was to analyze the quality and timeliness of notification of TB and TB-HIV co-infection cases from the Notifiable Diseases Information System (SINAN -Sistema de Informacao de Agravos de Notificacao) in Espirito Santo State, from 2016 to 2018. Methods: This is a cross-sectional study of the quality of SINAN data using the Centers for Disease Control and Prevention (CDC) guidelines to analyze the quality and timeliness of SINAN-TB notification, with emphasis on the description of TB-HIV co-infection in Espirito Santo State, from 2016 to 2018. It considered five methodological steps that included quality analysis, standardization of records, duplicity analysis, the completeness of data through linkage with the SINAN-HIV database and anonymization of data. It obtained ethical approval under the number 4022892 on 12/05/2020. Results: The study showed that 89% of mandatory variables and 91% of essential variables showed satisfactory completeness. In TB-HIV co-infection 73% of the variables were completed, but essential variables related to TB treatment follow-up showed unsatisfactory completeness. The timeliness of reporting was considered regular. Conclusion: Improvements in work processes and the development of a specific methodological process for data treatment are necessary to qualify the information available in SINAN-TB.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection
    Kwara, A
    Roahen-Harrison, S
    Prystowsky, E
    Kissinger, P
    Adams, R
    Mathison, J
    Hyslop, NE
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (05) : 485 - 493
  • [32] Human immunodeficiency virus and hepatitis C virus co-infection in Burundi
    Ntagirabiri, R.
    Ngendakumana, F.
    Niyongabo, T.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2012, 6 (02): : 128 - 131
  • [33] Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India
    Madan, Chandravali
    Chopra, Kamal Kishore
    Satyanarayana, Srinath
    Surie, Diya
    Chadha, Vineet
    Sachdeva, Kuldeep Singh
    Khanna, Ashwani
    Deshmukh, Rajesh
    Dutte, Lopamudra
    Namdeo, Amit
    Shukla, Ajay
    Sagili, Karuna
    Chauhan, Lakhbir Singh
    PLOS ONE, 2018, 13 (10):
  • [34] Tuberculosis, human immunodeficiency viruses and TB/HIV co-infection in pregnant women: A meta-analysis
    Yaghoubi, Atieh
    Salehabadi, Sepideh
    Abdeahad, Hossein
    Hasanian, Seyed Mahdi
    Avan, Amir
    Yousefi, Masoud
    Jamehdar, Saeid Amel
    Ferns, Gordon A.
    Khazaei, Majid
    Soleimanpour, Saman
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2020, 8 (04): : 1312 - 1320
  • [35] Human immunodeficiency virus and Candida albicans co-infection in Iran: a systematic review
    Soltani, Saber
    Farahani, Abbas
    Zebardast, Arghavan
    Dowran, Razieh
    Zandi, Milad
    Rafat, Zahra
    Sasani, Elahe
    Zarandi, Bahman
    Fallahy, Mohammad Taha Pahlevan
    Didehdar, Mojtaba
    HIV & AIDS REVIEW, 2023, 22 (03): : 181 - 188
  • [36] Human Immunodeficiency Virus/Syphilis Co-Infection in China: a Retrospective Observational Study
    Cheng, Juan
    Kuai, Dayu
    Huang, Huihuang
    Sun, Yongbing
    Xu, Hongxin
    Bai, Bingke
    Jiang, Tianjun
    SEXUALITY RESEARCH AND SOCIAL POLICY, 2024,
  • [37] Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection:: implications for pathogenesis
    Lawn, SD
    Rudolph, D
    Ackah, A
    Coulibaly, D
    Wiktor, S
    Lal, RB
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (04) : 449 - 452
  • [38] The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan
    El-Sony, AI
    HEALTH POLICY, 2006, 75 (03) : 272 - 279
  • [39] Association of TAP 1 and 2 gene polymorphisms with human immunodeficiency virus-tuberculosis co-infection
    Sunder, Sharada Ramaseri
    Hanumanth, Surekha Rani
    Gaddam, Sumanlatha
    Jonnalagada, Subbanna
    Valluri, Vijaya Lakshmi
    HUMAN IMMUNOLOGY, 2011, 72 (10) : 908 - 911
  • [40] Mycobacterium tuberculosis and human lymphotropic virus, a fatal co-infection
    Morales, Juan
    Montero, Leonardo
    REVISTA CHILENA DE INFECTOLOGIA, 2024, 41 (02): : 307 - 310